HOME >> BIOLOGY >> NEWS
Microbes in basalt thrive on mixed diet of toxic waste

BERKELEY, CA -- Seventy-five meters beneath the surface of a site in Idaho where high-level radioactive waste has been stored for more than 40 years, microorganisms living in the pores and crevices of dry basaltic rock are able to reduce a toxic form of chromium to a much less toxic form -- and they do so faster in the presence of volatile organic wastes.

Hoi-Ying Holman and her colleagues Dale Perry, Michael Martin, Wayne McKinney, and Jennie Hunter-Cevera of the Department of Energy's Lawrence Berkeley National Laboratory made the discovery by examining core samples from beneath the Radioactive Waste Management Complex at DOE's Idaho National Engineering and Environmental Laboratory. By using infrared spectromicroscopy at Berkeley Lab's Advanced Light Source (ALS), they were able to follow the reduction of toxic metals among populations of living organisms on minerals for the first time. The researchers will discuss their findings in the forthcoming October/November issue of Geomicrobiology Journal.

"We have shown that organic vapor may accelerate the transformation of mobile, toxic chromium pollutants into less mobile, less toxic, stable compounds," says Holman, a chemist and engineer with Berkeley Lab's Earth Sciences Division and the Center for Environmental Biotechnology (CEB). "This should help in the design and implementation of new, environmentally benign remediation techniques for cleaning up mixed waste sites."

The Idaho site is polluted with mixtures of hexavalent chromium and other inorganic ions, radionuclides, petroleum hydrocarbons, and volatile organic compounds. Hexavalent chromium (Cr6+) is carcinogenic, mutagenic, and highly toxic to living organisms because it occurs in soluble chromates that readily cross cell membranes. Once inside the cell, these ions are reduced (electrons are added) first to pentavalent chromium (Cr5+), then to trivalent chromium (Cr3+), which disrupts DNA replication.

Outs
'"/>

Contact: Paul Preuss
paul_preuss@lbl.gov
510-486-6249
DOE/Lawrence Berkeley National Laboratory
30-Aug-1999


Page: 1 2 3 4

Related biology news :

1. Microbes eat their way to better concrete
2. Microbes found in Mayan ruins may deteriorate stone from inside out
3. Microbes active in Colorado snows fuel tundra ecosystem
4. Microbes blueprints promise insights into oceans, more
5. Microbes related to infant lung infections reduced using specialized ventilation system device
6. Microbes and the dust they ride in on pose potential health risks
7. "Microbes deep within South African gold mines" subject of NSF lecture
8. Microbes make mine-waste drinkable, Science researchers report
9. Microbes on Earth may be key to identifying life on other planets
10. Microbes work magic on hazardous air pollutants
11. Chemical Reaction Believed To Support Underground Microbes Is Now Unlikely

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Microbes basalt thrive mixed diet toxic waste

(Date:3/11/2015)... , March 11, 2015   The ... its platform to scientifically measure and harness music ... to real-time biometrics and objective measurements of physiology, ... music at scale in large populations. It is ... technologists and clinicians perform rigorous studies and accelerate ...
(Date:3/10/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ... biometric authentication company focused on the growing mobile ... has been named the "Number One Best Tech ... Rethink Modern ( http://www.rethinkmodern.com/ ) is a web ... and lifestyle that have a unique function or design.  ...
(Date:3/2/2015)... SAN JOSE, Calif. , March 2, 2015 ... ), the leading developer of human interface solutions, ... ID technology that is designed to enable rapid ... Synaptics Natural ID™ module for gaming is a ... and ODMs the ability to quickly integrate fingerprint ...
Breaking Biology News(10 mins):Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 3NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 4Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3
(Date:3/30/2015)... , March 30, 2015 CASI Pharmaceuticals, Inc. ... the acquisition, development and commercialization of innovative therapeutics addressing ... market with a commercial focus on China ... Drug Administration (CFDA) has approved the Company,s application to ... clear cell carcinoma (OCCC) patients for its proprietary drug ...
(Date:3/30/2015)... GERMANTOWN, Md. , March 30, 2015  /PRNewswire/ ... a leader in synthetic biology, and Merck Serono, ... Germany , today announced an exclusive ... commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies. ... to develop innovative therapies that modulate the immune ...
(Date:3/30/2015)... Washington, USA (PRWEB) March 29, 2015 ... and the United States and plenary talks by four ... SPIE Optics + Optoelectronics next month in ... technical presentations in 17 conferences alongside a two-day exhibition. ... and photonics , the event will run 13-16 April ...
(Date:3/30/2015)... 2015  Naldemedine, an investigational peripherally acting mu-opioid ... Co., Ltd., met its primary and secondary endpoints ... the treatment of opioid-induced constipation (OIC) in adult ... Study results showed that naldemedine (0.2 mg tablet ... of spontaneous bowel movement (SBM) compared with placebo ...
Breaking Biology Technology:CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3
Cached News: